Prosper Junior Bakiny
TMFPBakiny
Prosper Junior Bakiny is a contributing Motley Fool healthcare analyst covering biotechnology, pharmaceuticals, and healthcare stocks. Before The Motley Fool, Prosper wrote about investing topics ranging from stock market news to private equity for various companies. He holds a master’s degree in corporate finance from the University of Maryland Global Campus.
Recent Articles by Prosper Junior Bakiny
Feb 16, 2025
by Prosper Junior Bakiny
2 Beaten-Down Stocks to Avoid
Feb 15, 2025
by Prosper Junior Bakiny
Is Teladoc Stock a Buy?
Feb 10, 2025
by Prosper Junior Bakiny
2 Stocks to Buy With Less Than $40
Feb 9, 2025
by Prosper Junior Bakiny
Is Summit Therapeutics a Millionaire Maker?
Feb 8, 2025
by Prosper Junior Bakiny
2 Stocks That Could Soar Again in 2025
Feb 7, 2025
by Prosper Junior Bakiny
Is CVS Health's Dividend Safe?
Feb 5, 2025
by Prosper Junior Bakiny
2 Monster Stocks to Buy and Hold Forever
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.